These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 26401934

  • 41. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease.
    Ziolko SK, Weissfeld LA, Klunk WE, Mathis CA, Hoge JA, Lopresti BJ, DeKosky ST, Price JC.
    Neuroimage; 2006 Oct 15; 33(1):94-102. PubMed ID: 16905334
    [Abstract] [Full Text] [Related]

  • 42. Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.
    Ossenkoppele R, Tolboom N, Foster-Dingley JC, Adriaanse SF, Boellaard R, Yaqub M, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN.
    Eur J Nucl Med Mol Imaging; 2012 Jun 15; 39(6):990-1000. PubMed ID: 22441582
    [Abstract] [Full Text] [Related]

  • 43. Regional brain hypometabolism is unrelated to regional amyloid plaque burden.
    Altmann A, Ng B, Landau SM, Jagust WJ, Greicius MD, Alzheimer’s Disease Neuroimaging Initiative.
    Brain; 2015 Dec 15; 138(Pt 12):3734-46. PubMed ID: 26419799
    [Abstract] [Full Text] [Related]

  • 44. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
    Fan Z, Okello AA, Brooks DJ, Edison P.
    Brain; 2015 Dec 15; 138(Pt 12):3685-98. PubMed ID: 26510952
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging.
    Chiotis K, Carter SF, Farid K, Savitcheva I, Nordberg A, Diagnostic Molecular Imaging (DiMI) network and the Alzheimer’s Disease Neuroimaging Initiative.
    Eur J Nucl Med Mol Imaging; 2015 Sep 15; 42(10):1492-506. PubMed ID: 26130168
    [Abstract] [Full Text] [Related]

  • 47. Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia.
    Mosconi L, Andrews RD, Matthews DC.
    J Alzheimers Dis; 2013 Sep 15; 35(3):509-24. PubMed ID: 23478305
    [Abstract] [Full Text] [Related]

  • 48. Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter Study.
    Ito K, Fukuyama H, Senda M, Ishii K, Maeda K, Yamamoto Y, Ouchi Y, Ishii K, Okumura A, Fujiwara K, Kato T, Arahata Y, Washimi Y, Mitsuyama Y, Meguro K, Ikeda M, SEAD-J Study Group.
    J Alzheimers Dis; 2015 Sep 15; 45(2):543-52. PubMed ID: 25589723
    [Abstract] [Full Text] [Related]

  • 49. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions.
    Klupp E, Förster S, Grimmer T, Tahmasian M, Yakushev I, Sorg C, Yousefi BH, Drzezga A.
    Brain Connect; 2014 Jun 15; 4(5):371-83. PubMed ID: 24870443
    [Abstract] [Full Text] [Related]

  • 50. Alzheimer's Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject.
    Tiepolt S, Patt M, Hoffmann KT, Schroeter ML, Sabri O, Barthel H.
    J Alzheimers Dis; 2015 Jun 15; 47(3):539-43. PubMed ID: 26401690
    [Abstract] [Full Text] [Related]

  • 51. Cortical hypermetabolism in MCI subjects: a compensatory mechanism?
    Ashraf A, Fan Z, Brooks DJ, Edison P.
    Eur J Nucl Med Mol Imaging; 2015 Mar 15; 42(3):447-58. PubMed ID: 25267349
    [Abstract] [Full Text] [Related]

  • 52. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
    Morbelli S, Bauckneht M, Arnaldi D, Picco A, Pardini M, Brugnolo A, Buschiazzo A, Pagani M, Girtler N, Nieri A, Chincarini A, De Carli F, Sambuceti G, Nobili F.
    Eur J Nucl Med Mol Imaging; 2017 Nov 15; 44(12):2073-2083. PubMed ID: 28785843
    [Abstract] [Full Text] [Related]

  • 53. Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay.
    Förster S, Grimmer T, Miederer I, Henriksen G, Yousefi BH, Graner P, Wester HJ, Förstl H, Kurz A, Dickerson BC, Bartenstein P, Drzezga A.
    Biol Psychiatry; 2012 May 01; 71(9):792-7. PubMed ID: 21679929
    [Abstract] [Full Text] [Related]

  • 54. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.
    Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ.
    Neurology; 2007 Feb 13; 68(7):501-8. PubMed ID: 17065593
    [Abstract] [Full Text] [Related]

  • 55. 18F-FDG and 18F-florbetapir PET in clinical practice: regional analysis in mild cognitive impairment and Alzheimer disease.
    Bailly M, Ribeiro MJ, Vercouillie J, Hommet C, Gissot V, Camus V, Guilloteau D.
    Clin Nucl Med; 2015 Feb 13; 40(2):e111-6. PubMed ID: 25549345
    [Abstract] [Full Text] [Related]

  • 56. A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227.
    Kaneta T, Okamura N, Minoshima S, Furukawa K, Tashiro M, Furumoto S, Iwata R, Fukuda H, Takahashi S, Yanai K, Kudo Y, Arai H.
    Ann Nucl Med; 2011 Dec 13; 25(10):732-9. PubMed ID: 21792587
    [Abstract] [Full Text] [Related]

  • 57. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM, Fripp J, Rowe CC, Villemagne VL, Salvado O, Rose S, Coulson EJ, Alzheimer's Disease Neuroimaging Initiative.
    Neuroimage Clin; 2015 Dec 13; 7():105-13. PubMed ID: 25610772
    [Abstract] [Full Text] [Related]

  • 58. Amyloid deposition and CBF patterns predict conversion of mild cognitive impairment to dementia.
    Kikukawa T, Abe T, Ataka S, Saito H, Hasegawa I, Mino T, Takeuchi J, Kawabe J, Wada Y, Watanabe Y, Itoh Y.
    Neurol Sci; 2018 Sep 13; 39(9):1597-1602. PubMed ID: 29936556
    [Abstract] [Full Text] [Related]

  • 59. Abnormal Amyloid Load in Mild Cognitive Impairment: The Effect of Reducing the PiB-PET Threshold.
    Ismail R, Parbo P, Hansen KV, Schaldemose JL, Dalby RB, Tietze A, Kjeldsen PL, la Cour SH, Qvist P, Gottrup H, Eskildsen SF, Brooks DJ.
    J Neuroimaging; 2019 Jul 13; 29(4):499-505. PubMed ID: 31074062
    [Abstract] [Full Text] [Related]

  • 60. Apathy is associated with increased amyloid burden in mild cognitive impairment.
    Marshall GA, Donovan NJ, Lorius N, Gidicsin CM, Maye J, Pepin LC, Becker JA, Amariglio RE, Rentz DM, Sperling RA, Johnson KA.
    J Neuropsychiatry Clin Neurosci; 2013 Jul 13; 25(4):302-7. PubMed ID: 24247857
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.